With the rise of the Intatient Foot and Outpatient, Patient Hair, and a continuous ramp of recently launched areas in 208.9 the Benefit of AED 67 million (US $ 507 million (US $ 50.9 million (US $ 507.
The increase in the Q2’s net benefit also is due to the footsteps of March 1 month, which was called the company to the sacred month of Ramadan.
Those numbers were excessive in the second quarter of the year, as the inpatient FotFall rose by 17.7 percent, and the outer foot grew 12 percent.
The income increased by 18,7 percent to 1.403 million (US $ 382 million) in Q2’25, while income of the first six months in AED 2,677.9 million). The complete patient’s visit reached for 3.4 million.
This group has made 22 930 surgery, up 18.7 Percentage. Sitting in bed is upgraded to 69 percent, up to 65 percent last year. Inpatient Rose 14.6 percent of the first part.
The decline in restrictions are driven by basic care and physiotherapy centers, and a solid need in Oncology, Pediatrics, OPHTHTHalmOology, and family medicine. The use is upgraded by 68 percent, from 65 percent in Q1’25.
OnCogy continued the key growth driver, which has 36.7 percent of the Q2’25 and 38.1 percent from H1’225. This is made of online network network and advanced treatment and advanced treatment. Some offers appoint good benefits to H1’25, including Rogel (+ 1 percent) and cardiology (+16 punt).
John Sunil, the Chief Executive Officer of Burjeel, commented: “The second quarter refers 12 results of 22 percent, the Personal Exparm Personal Strengthens higher powers.
“These results reflect visual progress in the active environment such as medical management, cost management, while focusing costs, while financial focus on high-quality care and maintenance.
“We also develop valuable interests, strengthening the leadership in the complex care of the entity, which is replacing, and cancer diagnosis.”
The BitDa stood up 59.4 percent 306 percent of 306 million (US $ 83.3 million) in Q2’25 million) in Q2’25. This includes 72 million (US $ 19.6 million) to the lease achievement following the discovery of Dubai Medoor hospital. EBITDA Margin has been increased 5.6 points for 21.8 percent.
In H1’225, EbitDa increases 14.2 percent of AED 487 million (US $ 132.6 million).
“The Burjeel Hands differently to include opportunators for advisors in the whole region, supported by the growing demand for complex care and increasing development.
“The growth of a 129 percent of the Net benefit benefit strengthens the trajectory and strengthens the foundation of the unstable shareholders return.”
